GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (LSE:BVXP) » Definitions » Short Percentage of Float

Bioventix (LSE:BVXP) Short Percentage of Float


View and export this data going back to 2014. Start your Free Trial

What is Bioventix Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Bioventix's Short Percentage of Float

For the Biotechnology subindustry, Bioventix's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioventix's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioventix's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Bioventix's Short Percentage of Float falls into.


;
;

Bioventix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioventix PLC (LSE:BVXP) » Definitions » Short Percentage of Float
Comparable Companies
LSE:AVCT LSE:HVO LSE:SCLP LSE:4BB LSE:IBT LSE:SBTX LSE:FARN LSE:OBI LSE:FUM LSE:TRX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
51B:Germany
Address
27–28 Eastcastle Street, London, GBR, W1W 8DH
Website
https://www.bioventix.com
Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country.

Bioventix Headlines

No Headlines